Control
Apr 21 2023 |
et al., Pharmaceuticals, doi:10.3390/ph16040631 | Pentoxifylline Effects on Hospitalized COVID-19 Patients with Cytokine Storm Syndrome: A Randomized Clinical Trial |
| 69% higher mortality (p=0.37) and 45% worse improvement (p=0.56). RCT 68 hospitalized COVID-19 patients with cytokine storm showing no significant improvement in clinical outcomes with pentoxifylline (PTX) treatment compared to standard therapy. While PTX demonstrated positive effects on inflammatory bi.. | ||
Dec 31 2021 |
et al., International Immunopharmacology, doi:10.1016/j.intimp.2021.108227 | Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial |
| 540% higher mortality (p=0.25). RCT 72 hospitalized COVID-19 patients showing no significant difference in clinical outcomes with pentoxifylline treatment compared to placebo. | ||
Jan 31 2021 |
et al., International Immunopharmacology, doi:10.1016/j.intimp.2020.107209 | Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study |
| 65% lower mortality (p=0.18), 54% lower ventilation (p=0.36), and 15% shorter hospitalization (p=0.33). Pilot study of 38 hospitalized COVID-19 patients in Mexico showing pentoxifylline treatment was associated with significantly increased lymphocyte count and decreased LDH levels compared to standard care. The pentoxifylline group (400mg t.. | ||
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. IMA and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.